July 16 (Reuters) - Prediction market platform Kalshi will start taking bets on the outcomes of clinical trials and FDA ...

Following a turbulent funding environment, biotechs are seeking to generate more data earlier to reassure investors.

Two innovative, forward-thinking organizations show how rebuilding patient trust is becoming the real breakthrough driving ...

The US Food and Drug Administration (FDA) has finalized a guidance for industry on development of drugs and therapeutic biologics for treating eosinophilic esophagitis (EoE), a chronic, allergic ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

Opportunities center on decentralized and hybrid trial platforms, AI-enabled recruitment and optimization, remote monitoring, ...

Some of the industry’s most closely-watched AI drugs could provide insight into the success of technology-assisted ...

GSK plc GSK on Friday announced a pivotal update regarding its Phase 3 clinical program for camlipixant, revealing a ...

The tuberculosis clinical trial analysis report delivers important insights into ongoing research of 30+ pipeline tuberculosis drugs, clinical strategies, upcoming therapeutics, and commercial ...

This Brush Up is sponsored by MilliporeSigma. Learn more about therapeutic synthesis pathways. Drug development is a process that spans many years, from the initial phase of identifying potential drug ...